Literature DB >> 8895497

Diethylnitrosamine exposure-responses for DNA damage, centrilobular cytotoxicity, cell proliferation and carcinogenesis in rat liver exhibit some non-linearities.

G M Williams1, M J Iatropoulos, C X Wang, N Ali, A Rivenson, L A Peterson, C Schulz, R Gebhardt.   

Abstract

The exposure-responses for several effects of limited exposures to diethylnitrosamine (DEN) in the livers of male Fischer 344 rats were measured and phenobarbital promotion was used to enhance expression of initiation of carcinogenesis. Five doses ranging from a cumulative total of 0.5 to 4 mmol DEN per kg body weight were given as weekly i.p. injections for 10 weeks. This was followed by 4 weeks recovery, after which the groups were maintained on either a basal diet or 0.05% phenobarbital (PB) to promote liver tumor development. All doses of DEN produced ethylation in liver DNA, which increased with dose. Indicative of toxicity, the centrilobular zone of glutamine synthetase-positive hepatocytes was reduced in relationship to exposure up to a cumulative exposure of 3 mmol/kg. The two lower exposures to DEN produced no increase in cell proliferation, whereas higher exposures resulted in marked increases, approximately 4-fold between 1.0 and 2.0 mmol/kg cumulative. At the end of the recovery period (14 weeks), hepatocellular altered foci (HAF), which expressed the placental form of glutathione S-transferase, were induced by all exposures, with an increase of approximately 4-fold between the exposures of 1.0 and 2.0 mmol/kg being the greatest. In rats maintained on basal diet or PB for 24 weeks after exposure, HAF increased further and with exposures of 2.0 mmol/kg and above, all rats developed hepatocellular carcinomas. With 1.0 mmol/kg, no liver tumor occurred in 12 rats without promotion, whereas in those given PB, two adenomas and two carcinomas were present in 12 rats. At the lowest exposure of 0.5 mmol/ kg, no tumor occurred in rats on basal diet, although HAF increased approximately 7-fold. With PB promotion, only one adenoma developed in 12 rats and HAF increased another 2-fold. Thus, the findings document non-linearity for some of the effects of DEN and a near no-effect level for initiation of promotable liver neoplasms at the lowest exposure in spite of a substantial induction of HAF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895497     DOI: 10.1093/carcin/17.10.2253

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Time-matched analysis of DNA adduct formation and early gene expression as predictive tool for renal carcinogenesis in methylazoxymethanol acetate treated Eker rats.

Authors:  Valentina Klaus; Heinke Bastek; Katja Damme; Leonard B Collins; Roland Frötschl; Norbert Benda; Dominik Lutter; Heidrun Ellinger-Ziegelbauer; James A Swenberg; Daniel R Dietrich; Kerstin Stemmer
Journal:  Arch Toxicol       Date:  2017-03-27       Impact factor: 5.153

2.  Interleukin-17A Plays a Pivotal Role in Chemically Induced Hepatocellular Carcinoma in Mice.

Authors:  Chao Sun; Hiroshi Kono; Shinji Furuya; Michio Hara; Kazuyoshi Hirayama; Yoshihiro Akazawa; Yuuki Nakata; Hideki Fujii
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

3.  Ductular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats.

Authors:  Andrea Janz Moreira; Graziella Ramos Rodrigues; Silvia Bona; Leila Xavier Sinigaglia Fratta; Giovana Regina Weber; Jaqueline Nascimento Picada; Jorge Luiz Dos Santos; Carlos Thadeu Cerski; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  Protoplasma       Date:  2016-08-15       Impact factor: 3.356

4.  Identification of Differential Protein Expression in Hepatocellular Carcinoma Induced Wistar Albino Rats by 2D Electrophoresis and MALDI-TOF-MS Analysis.

Authors:  Vadanasundari Vedarethinam; Karthik Dhanaraj; Ilavenil Soundherrajan; Ravikumar Sivanesan
Journal:  Indian J Clin Biochem       Date:  2015-05-26

5.  Clock gene Per2 as a controller of liver carcinogenesis.

Authors:  Ali Mteyrek; Elisabeth Filipski; Catherine Guettier; Alper Okyar; Francis Lévi
Journal:  Oncotarget       Date:  2016-12-27

6.  Preparation and biomedical application of a non-polymer coated superparamagnetic nanoparticle.

Authors:  Lin Du; Jianzhao Chen; Yanting Qi; Dan Li; Chonggang Yuan; Marie C Lin; David T Yew; Hsiang-Fu Kung; Jimmy C Yu; Lihui Lai
Journal:  Int J Nanomedicine       Date:  2007

7.  12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer.

Authors:  Ryuma Tokunaga; Shigeki Nakagawa; Yasuo Sakamoto; Kenichi Nakamura; Madiha Naseem; Daisuke Izumi; Keisuke Kosumi; Katsunobu Taki; Takaaki Higashi; Tatsunori Miyata; Yuji Miyamoto; Naoya Yoshida; Hideo Baba; Heinz-Josef Lenz
Journal:  Int J Cancer       Date:  2020-04-25       Impact factor: 7.316

8.  Restrained management of copper level enhances the antineoplastic activity of imatinib in vitro and in vivo.

Authors:  Iftekhar Hassan; Azmat Ali Khan; Shazia Aman; Wajhul Qamar; Hossam Ebaid; Jameel Al-Tamimi; Ibrahim M Alhazza; Ahmed M Rady
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

9.  Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats.

Authors:  Andrea J Moreira; Graziella Rodrigues; Silvia Bona; Carlos Thadeu Cerski; Claudio A Marroni; Jose L Mauriz; Javier González-Gallego; Norma P Marroni
Journal:  Toxicol Rep       Date:  2014-11-28

10.  Inhibition of early-phase exogenous and endogenous liver carcinogenesis in transgenic rats harboring a rat glutathione S-transferase placental form gene.

Authors:  D Nakae; A Denda; Y Kobayashi; H Akai; H Kishida; T Tsujiuchi; Y Konishi; T Suzuki; M Muramatsu
Journal:  Jpn J Cancer Res       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.